CLINICAL_TRIALS
trial_result
· 2012-03-30
Clinical Trial Update: Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation [Phase 2]
Summary
A Phase 2 dose-ranging trial evaluating an ivermectin-based treatment conditioner for head lice infestation has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Topaz Pharmaceuticals Inc | Conditions: Pediculus Humanus Capitis (Head Lice) | Phase 2 | Status: COMPLETED | Results posted: 2012-03-30